4.6 Article

Genomic Signature of Oral Squamous Cell Carcinomas from Non-Smoking Non-Drinking Patients

期刊

CANCERS
卷 13, 期 5, 页码 -

出版社

MDPI
DOI: 10.3390/cancers13051029

关键词

oral cancer; tobacco; alcohol; human papilloma virus; targeted sequencing; DNA copy number; TP53; CDKN2A; EGFR; PIK3CA

类别

资金

  1. Jack Tindall Bequest
  2. Price Family Foundation
  3. Australian and New Zealand Head and Neck Cancer Society
  4. Independent Research Institutes Infrastructure Support Scheme Grant
  5. Victorian State Government Operational Infrastructure Support Grant
  6. Garnett Passe and Rodney Williams Memorial Foundation
  7. National Health and Medical Research Council (NHMRC) [APP1136119]

向作者/读者索取更多资源

A distinct cohort of non-smoking non-drinking patients with oral cavity squamous cell carcinomas have been identified, showing specific genomic profiles different from patients who smoke and/or drink, with associations to mutations in TP53, CDKN2A, EGFR, and BRCA2 genes. Further exploration is needed to elucidate the molecular aetiology in these patients.
Simple Summary A clinically distinct cohort of non-smoking non-drinking patients who develop oral cavity squamous cell carcinomas has been identified, with previous work suggesting that these patients tend to be older, female, and have poor outcomes. Our study characterised tumour molecular alterations in these patients, identifying differences in genomic profiles as compared to patients who smoke and/or drink. Associations between molecular alterations and other clinical and pathological characteristics were also explored. Molecular alterations in 176 patients with oral squamous cell carcinomas (OSCC) were evaluated to delineate differences in non-smoking non-drinking (NSND) patients. Somatic mutations and DNA copy number variations (CNVs) in a 68-gene panel and human papilloma virus (HPV) status were interrogated using targeted next-generation sequencing. In the entire cohort, TP53 (60%) and CDKN2A (24%) were most frequently mutated, and the most common CNVs were EGFR amplifications (9%) and deletions of BRCA2 (5%) and CDKN2A (4%). Significant associations were found for TP53 mutation and nodal disease, lymphovascular invasion and extracapsular spread, CDKN2A mutation or deletion with advanced tumour stage, and EGFR amplification with perineural invasion and extracapsular spread. PIK3CA mutation, CDKN2A deletion, and EGFR amplification were associated with worse survival in univariate analyses (p < 0.05 for all comparisons). There were 59 NSND patients who tended to be female and older than patients who smoke and/or drink, and showed enrichment of CDKN2A mutations, EGFR amplifications, and BRCA2 deletions (p < 0.05 for all comparisons), with a younger subset showing higher mutation burden. HPV was detected in three OSCC patients and not associated with smoking and drinking habits. NSND OSCC exhibits distinct genomic profiles and further exploration to elucidate the molecular aetiology in these patients is warranted.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据